Anti-mullerian Hormone Levels in Healthy Females
ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeUp to 18
SponsorErin Rowell
About this trial
The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.
Eligibility criteria
Qualifiers
Pre- and post-pubertal females
Ages 0-18 years old
Tanner Stage I- V
Undergoing routine outpatient surgical procedure
Disqualifiers
Previous diagnosis of an illness associated with premature ovarian failure (Turner's syndrome, Fragile X permutation carrier) or endocrine disorder associated with irregular menstrual cycles (Cushing's disease, poorly-controlled Thyroid disease, hyperprolactinemia, polycystic ovary syndrome, and congenital adrenal hyperplasia) or insulin-dependent diabetes mellitus or autoimmune disorders
Previous diagnosis of any malignancy or any history of systemic/local chemotherapy, radiation therapy, or stem-cell transplant.
Previous surgical excision of one ovary or both ovaries
Pregnant females
Trial design
Treatments tested in this trial
- Blood sample collection
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Erin Rowell
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Sponsor institution
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Source ClinicalTrials.gov